Literature DB >> 18058461

Telomere length in hepatocellular carcinoma and paired adjacent non-tumor tissues by quantitative PCR.

Yujing Zhang1, Jing Shen, Yu Po-Huang Lee, Regina M Santella.   

Abstract

Telomere shortening limits the proliferative capacity of human cells, restrains the regenerative capacity of organ systems during chronic diseases and aging and also induces chromosomal instability as well as initiation of cancer. Previous studies demonstrated that telomeres are often significantly shorter in tumor tissue, including hepatocellular carcinoma (HCC), compared to the surrounding tissue, but telomere length in HCC tissues was not correlated with several clinical parameters, such as age, sex, HBV or HCV infections and tumor size. In the present study, the telomere length ratio of 36 paired HCC, and their adjacent non-tumor tissues was measured by quantitative PCR (Q-PCR). The mean telomere lengths (SD) for HCC and adjacent non-tumor tissues were 0.26 (0.10) and 0.47 (0.20) respectively (t = 6.22, P < 0.0001). There was a large difference in the distribution of subjects based on telomere length in tumor and adjacent non-tumor tissues. The number of tumors with telomere length shorter than 0.50 was much higher than that of adjacent non-tumor tissues; more than 90% of the tissues with telomere length > or = 0.50 were adjacent non-tumor tissues. The correlations between telomere length and aflatoxin B1- and polycyclic aromatic hydrocarbon-DNA adducts level, p53 mutations and p16 hypermethylation status were also tested, but no significant associations were found. The relationship between telomere length shortening, chemical carcinogen exposure, and genetic and epigenetic changes in hepatocarcinogenesis needs further investigation.

Entities:  

Mesh:

Year:  2007        PMID: 18058461     DOI: 10.1080/07357900701561024

Source DB:  PubMed          Journal:  Cancer Invest        ISSN: 0735-7907            Impact factor:   2.176


  7 in total

1.  A novel pooled-sample multiplex luminex assay for high-throughput measurement of relative telomere length.

Authors:  Farzana Jasmine; Justin Shinkle; Mekala Sabarinathan; Habibul Ahsan; Brandon L Pierce; Muhammad G Kibriya
Journal:  Am J Hum Biol       Date:  2018-03-12       Impact factor: 1.937

2.  Telomere Length and Risk of Hepatocellular Carcinoma: A Nested Case-control Study in Taiwan Cancer Screening Program Cohort.

Authors:  Hui Zeng; Hui-Chen Wu; Qiao Wang; Hwai-I Yang; Chien-Jen Chen; Regina M Santella; Jing Shen
Journal:  Anticancer Res       Date:  2017-02       Impact factor: 2.480

3.  Measurement of telomere length: a new assay using QuantiGene chemistry on a Luminex platform.

Authors:  Muhammad G Kibriya; Farzana Jasmine; Shantanu Roy; Habibul Ahsan; Brandon Pierce
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-12       Impact factor: 4.254

4.  Telomere Length and Survival of Patients with Hepatocellular Carcinoma in the United States.

Authors:  Baiyu Yang; Fatma M Shebl; Lawrence R Sternberg; Andrew C Warner; David E Kleiner; Daniel C Edelman; Allison Gomez; Casey L Dagnall; Belynda D Hicks; Sean F Altekruse; Brenda Y Hernandez; Charles F Lynch; Paul S Meltzer; Katherine A McGlynn
Journal:  PLoS One       Date:  2016-11-23       Impact factor: 3.240

5.  Telomerecat: A ploidy-agnostic method for estimating telomere length from whole genome sequencing data.

Authors:  James H R Farmery; Mike L Smith; Andy G Lynch
Journal:  Sci Rep       Date:  2018-01-22       Impact factor: 4.379

6.  Paired assessment of liver telomere lengths in hepatocellular cancer is a reliable predictor of disease persistence.

Authors:  Wendu Feng; Decai Yu; Binghua Li; Ou-Yang Luo; Tiancheng Xu; Yajuan Cao; Yitao Ding
Journal:  Biosci Rep       Date:  2017-03-15       Impact factor: 3.840

Review 7.  Telomere Dynamics in Immune Senescence and Exhaustion Triggered by Chronic Viral Infection.

Authors:  Marcia Bellon; Christophe Nicot
Journal:  Viruses       Date:  2017-10-05       Impact factor: 5.048

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.